Predicate | Object |
---|---|
rdf:type | |
http://www.biopax.org/relea... |
cpath:CPATH-LOCAL-265984,
cpath:CPATH-LOCAL-265984,
cpath:CPATH-LOCAL-265985,
cpath:CPATH-LOCAL-265985,
cpath:CPATH-LOCAL-265986,
cpath:CPATH-LOCAL-265986,
cpath:CPATH-LOCAL-265987,
cpath:CPATH-LOCAL-265987,
cpath:CPATH-LOCAL-265988,
cpath:CPATH-LOCAL-265988,
cpath:CPATH-LOCAL-270579,
cpath:CPATH-LOCAL-270579
|
http://www.biopax.org/relea... |
Signal transducer and activator of transcription 5B,
Signal transducer and activator of transcription 5B
|
http://www.biopax.org/relea... |
STA5B_HUMAN,
STA5B_HUMAN
|
http://www.biopax.org/relea... | |
http://www.biopax.org/relea... |
FUNCTION: Carries out a dual function: signal transduction and activation of transcription. Binds to the GAS element and activates PRL-induced transcription. SUBUNIT: Forms a homodimer or a heterodimer with a related family member. Binds NR3C1 (By similarity). Interacts with NCOA1, NMI and SOCS7. SUBCELLULAR LOCATION: Cytoplasm (By similarity). Nucleus (By similarity). Note=Translocated into the nucleus in response to phosphorylation (By similarity). PTM: Tyrosine phosphorylated in response to signaling via activated FLT3; wild-type FLT3 results in much weaker phosphorylation than constitutively activated mutant FLT3. Alternatively, can be phosporylated by JAK2. DISEASE: Defects in STAT5B are the cause of Laron type dwarfism II (LTD2) [MIM:245590]; also known as Laron syndrome type II or Laron syndrome due to a post-receptor defect. The phenotypic features are consistent with growth hormone deficiency in the presence of normal to elevated circulating concentrations of growth hormone, and resistance to hexogeneous hormone therapy. SIMILARITY: Belongs to the transcription factor STAT family. SIMILARITY: Contains 1 SH2 domain. WEB RESOURCE: Name=STAT5Bbase; Note=STAT5B mutation db; URL="http://bioinf.uta.fi/STAT5Bbase/"; WEB RESOURCE: Name=Wikipedia; Note=STAT5 entry; URL="http://en.wikipedia.org/wiki/STAT5"; COPYRIGHT: Protein annotation is derived from the UniProt Consortium (http://www.uniprot.org/). Distributed under the Creative Commons Attribution-NoDerivs License.,
FUNCTION: Carries out a dual function: signal transduction and activation of transcription. Binds to the GAS element and activates PRL-induced transcription. SUBUNIT: Forms a homodimer or a heterodimer with a related family member. Binds NR3C1 (By similarity). Interacts with NCOA1, NMI and SOCS7. SUBCELLULAR LOCATION: Cytoplasm (By similarity). Nucleus (By similarity). Note=Translocated into the nucleus in response to phosphorylation (By similarity). PTM: Tyrosine phosphorylated in response to signaling via activated FLT3; wild-type FLT3 results in much weaker phosphorylation than constitutively activated mutant FLT3. Alternatively, can be phosporylated by JAK2. DISEASE: Defects in STAT5B are the cause of Laron type dwarfism II (LTD2) [MIM:245590]; also known as Laron syndrome type II or Laron syndrome due to a post-receptor defect. The phenotypic features are consistent with growth hormone deficiency in the presence of normal to elevated circulating concentrations of growth hormone, and resistance to hexogeneous hormone therapy. SIMILARITY: Belongs to the transcription factor STAT family. SIMILARITY: Contains 1 SH2 domain. WEB RESOURCE: Name=STAT5Bbase; Note=STAT5B mutation db; URL="http://bioinf.uta.fi/STAT5Bbase/"; WEB RESOURCE: Name=Wikipedia; Note=STAT5 entry; URL="http://en.wikipedia.org/wiki/STAT5"; COPYRIGHT: Protein annotation is derived from the UniProt Consortium (http://www.uniprot.org/). Distributed under the Creative Commons Attribution-NoDerivs License.
|
skos:exactMatch | |
skos:closeMatch |